Missouri Trust & Investment Company’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.11M Sell
1,205
-210
-15% -$213K 0.33% 66
2025
Q4
$1.52M Hold
1,415
0.45% 50
2025
Q3
$1.08M Buy
1,415
+300
+27% +$223K 0.32% 62
2025
Q2
$869K Buy
1,115
+58
+5% +$45.1K 0.28% 70
2025
Q1
$873K Sell
1,057
-25
-2% -$20.8K 0.31% 65
2024
Q4
$835K Buy
1,082
+50
+5% +$41.4K 0.29% 71
2024
Q3
$914K Hold
1,032
0.32% 64
2024
Q2
$934K Sell
1,032
-28
-3% -$22.4K 0.35% 62
2024
Q1
$825K Buy
1,060
+145
+16% +$103K 0.32% 68
2023
Q4
$533K Hold
915
0.22% 83
2023
Q3
$491K Sell
915
-4
-0.4% -$2.06K 0.22% 83
2023
Q2
$431K Buy
919
+145
+19% +$60.8K 0.24% 86
2023
Q1
$266K Buy
774
+24
+3% +$8.09K 0.17% 98
2022
Q4
$274K Buy
750
+300
+67% +$106K 0.16% 94
2022
Q3
$146K Hold
450
0.1% 115
2022
Q2
$146K Buy
450
+15
+3% +$4.5K 0.1% 115
2022
Q1
$125K Buy
435
+35
+9% +$9.01K 0.07% 125
2021
Q4
$110K Buy
+400
New +$101K 0.06% 138

Other funds holding LLY

Missouri Trust & Investment Company's LLY Position: Q1 2026 in Review

Missouri Trust & Investment Company reduced its Eli Lilly (LLY) stake by 15% in Q1 2026, selling an estimated $213K and leaving 1,205 shares worth $1.11M. The position accounts for 0.33% of the portfolio, ranked #66.

Missouri Trust & Investment Company first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.52M in Q4 2025. 4,363 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Missouri Trust & Investment Company held 1,205 shares of Eli Lilly worth $1.11M as of Q1 2026.
  • Missouri Trust & Investment Company sold 210 Eli Lilly shares in Q1 2026, an estimated $213K.
  • Eli Lilly made up 0.33% of Missouri Trust & Investment Company's portfolio in Q1 2026, its #66 holding.
  • Missouri Trust & Investment Company first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
  • Missouri Trust & Investment Company's Eli Lilly position peaked at $1.52M in Q4 2025.
  • 4,363 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Missouri Trust & Investment Company's 13F filing for Q1 2026, filed 14 May 2026.